Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 3.91 Billion | USD 5.61 Billion | 4.1% | 2023 |
According to the report published by Zion Market Research, the global Pharmaceutical Solvents Market size was valued at USD 3.91 Billion in 2023 and is predicted to reach USD 5.61 Billion by the end of 2032. The market is expected to grow with a CAGR of 4.1% during the forecast period.
The report analyzes the global Pharmaceutical Solvents Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Pharmaceutical Solvents industry.
Solvents are known as liquid substances that are capable of dissolving or dispersing multiple substances. Such solvents are referred to as indispensable building blocks due to their wide range of advantages like higher stability in storage and no sensitivity to oxidation. Pharmaceutical solvents are the kind of chemical substances utilized during a drug manufacturing process. They are used for the extraction and purification of a particular material without modifying the materials chemically. The pharmaceutical solvents function as reaction mediums and offer molecules for drug preparation.
Pharmaceutical companies use a wide range of chemicals in different propositions and combinations. However, it is not always possible to formulate the desired chemical composition after forming chemical bonds with each other. Therefore, these solvents are utilized to extract desired blended combinations. Solvents are a kind of chemical materials that can extract, suspend, segregate, or dissolve other chemicals. A solvent can also be utilized either in the form of gas, liquid, or solid depending on the requirement of the various reactions. Pharmaceutical solvents act as a reaction medium or as a catalyst for extracting the required composition of drugs. Therefore, such requirements are likely to steer the growth of the global pharmaceutical solvents market over the forecasted period. Apart from that, solvents are also used as rinsing liquids or disinfectants in the pharmaceutical sector. The pharmaceutical solvent cannot be wholly eliminated from the final drugs.
Drug innovation and manufacturing processes are steering the growth of the pharmaceutical sector globally, which in turn is likely to create several lucrative growth opportunities in the global pharmaceutical solvents market over the forecasted period. The growing government drug regulations and research & development activities are further positively impacting the growth of the market.
Also, the adoption of manufacturing technologies and innovative methods in the pharmaceutical sector is another crucial factor steering the growth of the global pharmaceutical solvents market. The high prevalence of chronic diseases along with growing complexities inpatient demands for advanced biologics and biosimilars. Such demands will nuance the packaging solutions. The packaging solution is in parallel with RS limits of solvent used, which in turn will also enhance the traceability and quality. Also, the growing initiatives from the government to adopt green chemical processes due to their unique advantages like non-inflammable properties are also widening the scope of pharmaceutical solvents globally.
Pharmaceutical companies boost revenue by keeping solvent recovery on-site instead of depending on chemical processes. However, all these aforementioned factors are likely to bolster the growth of the global pharmaceutical solvents market over the forecasted period.
The global pharmaceutical solvents market can be segmented into chemical groups and regions.
By chemical group, the market can be segmented into chlorinated solvents, ether, ester, amine, alcohol, and others. The chlorinated solvents segment can further be bifurcated into dichloromethane and carbon tetrachloride. The ether segment can further be bifurcated into polyethylene glycol, anisole, and diethyl ether. The ester segment can further be bifurcated into butyl acetate, ethyl acetate, and acetyl acetate. The amine segment can further be bifurcated into trimethylamine, dimethylethanolamine, diphenylamine, and aniline.
The alcohol segment can further be bifurcated into propylene glycol, propanol isopropanol, and ethanol. The alcohol segment accounts for the largest share in the global pharmaceutical solvents market. Among the classifications, the propanol segment holds hegemony over others as it is highly used as direct solvents in pharmaceuticals. It is also used to produce cleaning agents, dyes, soaps, and others. The alcohol-based pharmaceutical solvents are extensively utilized in OTC syrups and drugs.
Report Attributes | Report Details |
---|---|
Report Name | Pharmaceutical Solvents Market |
Market Size in 2023 | USD 3.91 Billion |
Market Forecast in 2032 | USD 5.61 Billion |
Growth Rate | CAGR of 4.1% |
Number of Pages | 193 |
Key Companies Covered | Bayer Group, LyondellBasell Industries Holdings BV, FINAR LIMITED, Akzonobel N.V., Pon Pure Chemicals, Nouryon, DuPont de Nemours, Inc, Eastman Chemical Company, Bayer AG, Exxon Mobil Corporation, Merck KGaA, BASF SE, The Dow Chemical Company, and Mitsubishi Chemical Corporation |
Segments Covered | By Chemical Groups and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Asia Pacific accounts for the largest share in the global pharmaceutical solvents market due to the fast proliferation of the pharmaceutical sector in the region. Also, the growing economies like South Korea, Japan, and China are likely to pose huge demand for the pharmaceutical segment in the upcoming years due to the growing initiatives from the government to strengthen the healthcare infrastructure in the region and provide high-end treatment to the patients.
North America is likely to register a significant growth rate over the forecasted period due to the presence of robust medical device manufacturers in the region. Also, the growing investments to fuel research and development activities in the pharmaceutical sector are likely to further stimulate the growth of the regional market.
The global pharmaceutical solvents market is led by players like:
By Chemical Groups
Global Pharmaceutical Solvents Market: Regional Segment Analysis
What Reports Provides
FrequentlyAsked Questions
Solvents are liquid substances that have the capacity to dissolve or disperse multiple substances. Due to their extensive array of benefits, including their resistance to oxidation and enhanced storage stability, these solvents are termed "indispensable building blocks." Pharmaceutical solvents are chemical substances that are employed in the fabrication of drugs.
Different propositions and combinations of substances are used by pharmaceutical firms in a vast spectrum. Still, it is not always possible to create the intended chemical composition once chemical bonds have been formed between one other. These solvents are thus used to extract intended mixed combinations. Solvents are a type of chemical materials capable of extracting, suspending, separating, or dissolving other compounds. Depending on the necessity of the several reactions, a solvent can also be used as gas, liquid, or solid.
The global Pharmaceutical Solvents Market size was valued at USD 3.91 Billion in 2023 and is predicted to reach USD 5.61 Billion by the end of 2032.
The market is expected to grow with a CAGR of 4.1% during the forecast period.
Asia Pacific accounts for the largest share in the global pharmaceutical solvents market due to the fast proliferation of the pharmaceutical sector in the region. Also, the growing economies like South Korea, Japan, and China are likely to pose huge demand for the pharmaceutical segment in the upcoming years due to the growing initiatives from the government to strengthen the healthcare infrastructure in the region and provide high-end treatment to the patients.
Bayer Group, LyondellBasell Industries Holdings BV, FINAR LIMITED, Akzonobel N.V., Pon Pure Chemicals, Nouryon, DuPont de Nemours, Inc, Eastman Chemical Company, Bayer AG, Exxon Mobil Corporation, Merck KGaA, BASF SE, The Dow Chemical Company, and Mitsubishi Chemical Corporation
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed